UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 9, 2016
Accession Number:
0001193125-16-759022
Submission Type:
POS AM
CIK:
0001311596
Company Name:
Tobira Therapeutics, Inc.
File Number:
333-204701